Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of defense healthcare system

Cancer

Volumn 98, Issue 5, 2003, Pages 894-899

  Jatoi, Ismail ^a,d   Becher, Heiko ^b   Leake, Charles R ^c  

^a US Army Hospital   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c United States Army Center for Army Analysis   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

African American; Breast carcinoma; Racial disparity; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CAUSE OF DEATH; DATA BASE; FEMALE; FOLLOW UP; GOVERNMENT; HAZARD ASSESSMENT; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; MILITARY PERSONNEL; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0041887167     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11604     Document Type: Article

References (30)

1. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
2. Chevarley F, White E. Recent trends in breast cancer mortality among White and Black US women. Am J Public Health. 1997;87:775-781.
3. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. JAMA. 1994;272:947-954.
4. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among White, Hispanic, and Black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
5. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:90-96.
6. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
7. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329: 326-331.
8. Welch GH, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000;283:2975-2978.
9. Harris EK, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker, 1991.
10. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002;20:3302-3316.
11. McTigue KM, Garrett JM, Popkin BM. The natural history of the development of obesity in a cohort of young US adults between 1981 and 1998. Ann Intern Med. 2002;136:857-864.
12. Rose DP, Royak-Schaler R. Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev. 2001;25:16-31.
13. Wood AJJ. Racial differences in the response to drugs-pointers to genetic differences. N Engl J Med. 2001;344:1393-1395.
14. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52:326-341.
15. Dignam JJ. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr. 2001;30:36-43.
16. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs Medical System. N Engl J Med. 1993;329:621-627.
17. Chen J, Rathosre SS, Radford MJ, Wang Y, Krumholz HM. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001;344:1443-1449.
18. Jatoi I, Miller AB. Why is breast cancer mortality declining? Lancet Oncol. 2003;4:251-254.
19. Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control. 1991;2:67-74.
20. Jatoi I, Baum M. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer? Surgery. 1995;118:118-120.
21. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increase in mammography utilization? Am J Epidemiol. 1992;136:1423-1436.
22. Richards M, Sainsbury R, Kerr D. Inequalities in breast cancer care and outcome. Br J Cancer. 1997;76:634-638.
23. Sant M, Capocaccia R, Coleman MP, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer. 2001;37:1659-1667.
24. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995;345:1251-1252.
25. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ. 1996;312:145-148.
26. Reynolds T. Declining breast cancer mortality: what's behind it? J Natl Cancer Inst. 1999;91:750-753.
27. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1992;339:1-15, 71.
28. Olivotto IA, Bajdik CD, Plenderleith IH, et al. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med. 1994;330:805-810.
29. Optenberg SA, Thompson IM, Friedrichs P. Race, treatment, and long-term survival from prostate cancer in an equal-access medical delivery system. JAMA. 1995;274:1599-1605.
30. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998;82: 1310-1318.